Online citations, reference lists, and bibliographies.
← Back to Search

Alternative Strategies For The Application Of Aminoglycoside Antibiotics Against The Biofilm-forming Human Pathogenic Bacteria

Fazlurrahman Khan, Dung Pham, Y. Kim
Published 2020 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Aminoglycosides are one of the common classes of antibiotics that have been widely used for treating infections caused by pathogenic bacteria. The mechanism of bactericidal action by aminoglycosides is well-known, by which it terminates the cytoplasmic protein synthesis. However, the potentials of aminoglycosides become hindered when facing the evolution of bacterial resistance mechanisms. Among multiple resistance mechanisms displayed by bacteria against antibiotics, the formation of biofilm is the mechanism that provides a barrier for antibiotics to reach the cellular level. Bacteria present in the biofilm also get protection against the impact of host immune responses, harsh environmental conditions, and other antimicrobial treatments. Hence, with the multifaceted resistance developed by biofilm-forming pathogenic bacteria, antibiotics are therefore discontinued for further applications. However, the recent research developed several alternative strategies such as optimization of the active concentration, modification of the environmental conditions, modification of the chemical structure, combinatorial application with other active agents, and formulation with biocompatible carrier materials to revitalize and exploit the new potential of aminoglycosides. The present review article describes the above mentioned multiple approaches and possible mechanisms for the application of aminoglycosides to treat biofilm-associated infections.
This paper references
Inhibition of bacterial
I Spiliopoulou (2015)
10.1128/AAC.01118-16
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics
S. Nair (2016)
10.1038/nrd3013
Anti-virulence strategies to combat bacteria-mediated disease
D. Rasko (2010)
Gentamicin modified chitosan
Y Liu (2017)
10.1016/j.jgar.2017.03.006
Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin.
Shahin Bahari (2017)
10.3389/fmicb.2013.00121
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
M. Ramirez (2013)
10.1093/jac/dku357
Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
S. Moreau-Marquis (2015)
10.1128/AAC.43.4.727
Aminoglycosides: Activity and Resistance
M. Mingeot-Leclercq (1999)
10.1128/AAC.00196-16
Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections
E. Rojo-Molinero (2016)
10.1166/JBN.2015.2160
Inhibition of Bacterial Attachment on Surfaces by Immobilization of Tobramycin-Loaded Liposomes.
S. Mourtas (2015)
10.1111/2049-632X.12015
Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.
G. G. Anderson (2013)
Continuous release of gentamicin
S 3389fmicb.2019.02091 Perni (2014)
Synthesis and evaluation of a chitosan oligosaccharidestreptomycin conjugate against Pseudomonas aeruginosa biofilms
R Li (2019)
Dorotkiewicz-Jach A (2010) Liposomes as delivery
Z Drulis-Kawa (2010)
10.1002/anie.201506814
Di-N-Methylation of Anti-Gram-Positive Aminoglycoside-Derived Membrane Disruptors Improves Antimicrobial Potency and Broadens Spectrum to Gram-Negative Bacteria.
R. Benhamou (2015)
10.2147/IJN.S182611
Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity
Dina A Mosselhy (2018)
10.1099/mic.0.054320-0
Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
Y. Morita (2012)
10.1016/j.ijantimicag.2018.12.015
Formation of Pseudomonas aeruginosa inhibition zone during tobramycin disk diffusion is due to transition from planktonic to biofilm mode of growth.
N. Høiby (2019)
10.1128/AAC.02161-12
Streptomycin Inhibits Quorum Sensing in Acinetobacter baumannii
Sunil D Saroj (2013)
10.1016/J.REACTFUNCTPOLYM.2019.01.013
Synthesis of gentamicin-grafted-chitosan with improved solubility and antibacterial activity
Tingting Yan (2019)
10.1016/J.ARABJC.2017.05.011
Nanoparticles: Properties, applications and toxicities
I. Khan (2017)
Nanocarriers for antibiotics: a promising
N Abed (2014)
10.1016/J.IJPHARM.2005.10.005
Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics.
Clement Mugabe (2006)
10.1021/mp500846u
Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms.
Ju Du (2015)
10.1101/601336
Synergistic interactions of quercetin with antibiotics against biofilm associated clinical isolates of Pseudomonas aeruginosa in vitro
C. Vipin (2019)
10.1371/journal.pone.0081132
Subinhibitory Concentration of Kanamycin Induces the Pseudomonas aeruginosa type VI Secretion System
C. Jones (2013)
10.2147/IJN.S74469
The ability of streptomycin-loaded chitosan-coated magnetic nanocomposites to possess antimicrobial and antituberculosis activities
M. E. El Zowalaty (2015)
10.1093/jac/dkv044
In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
D. Lebeaux (2015)
10.2741/4284
Gold nanoparticles: various methods of synthesis and antibacterial applications.
Monic Shah (2014)
10.1038/srep18877
Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria
H. Mu (2016)
10.1016/j.chembiol.2019.09.015
Membrane-Active Rhamnolipids Overcome Aminoglycoside Resistance.
Venkateswarlu Yarlagadda (2019)
Potentiation of antibiotic
S Bhattacharjee (2017)
10.1111/jam.13476
Potentiation of antibiotic against Pseudomonas aeruginosa biofilm: a study with plumbagin and gentamicin
P. Gupta (2017)
10.1016/j.carbpol.2017.10.061
Synthesis of hyaluronan-amikacin conjugate and its bactericidal activity against intracellular bacteria in vitro and in vivo.
Zhaojie Wang (2018)
10.1128/AAC.02533-15
Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor
A. Furiga (2015)
10.1039/c7cs00407a
Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.
Nishad Thamban Chandrika (2018)
10.3390/ijms151222296
Chitosan Improves Anti-Biofilm Efficacy of Gentamicin through Facilitating Antibiotic Penetration
Haibo Mu (2014)
Aminoglycosides: A Practical Review
González Rd (1998)
Chemical induction of aminoglycoside
P Eswara (2019)
2016) Aminoglycosides: an overview
KM Krause (2016)
10.1128/JB.00779-06
Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
N. Barraud (2006)
10.1371/journal.pone.0194556
Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation
Y. Sato (2018)
New amphiphilic neamine derivatives active
MP Leclercq (2014)
10.1007/s10853-018-1998-9
Synthesis of chitosan/poly (ethylene glycol)-modified magnetic nanoparticles for antibiotic delivery and their enhanced anti-biofilm activity in the presence of magnetic field
X. Wang (2018)
10.4248/IJOS11022
The role of bacterial biofilm in persistent infections and control strategies
L. Chen (2011)
10.1590/S1517-83822013000100037
Effect of sub-minimum inhibitory concentrations of ciprofloxacin, amikacin and colistin on biofilm formation and virulence factors of Escherichia coli planktonic and biofilm forms isolated from human urine
Dorota Wojnicz (2013)
10.1128/AAC.02536-13
New Amphiphilic Neamine Derivatives Active against Resistant Pseudomonas aeruginosa and Their Interactions with Lipopolysaccharides
Guillaume Sautrey (2014)
Intra- and inter-species interactions within
M Simoes (2015)
10.1038/srep43321
Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum
Aurélie Crabbé (2017)
10.1016/j.mib.2018.07.006
Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials.
Michael R. M. Ranieri (2018)
10.1128/AAC.01603-17
Interplay between Antibiotic Efficacy and Drug-Induced Lysis Underlies Enhanced Biofilm Formation at Subinhibitory Drug Concentrations
W. Yu (2017)
10.1021/acsinfecdis.8b00001
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes.
G. Cox (2018)
10.1039/C8TB01245H
Recent developments in smart antibacterial surfaces to inhibit biofilm formation and bacterial infections.
Xi Li (2018)
Chitosan conju
H Mu (2016)
Improved biofilm antimicrobial activity
HD Smyth (2015)
Quercetin influences quorum
V Gopu (2015)
10.1128/AAC.00001-13
Extracellular DNA Shields against Aminoglycosides in Pseudomonas aeruginosa Biofilms
W. Chiang (2013)
10.1208/s12249-014-0200-1
Sound Waves Effectively Assist Tobramycin in Elimination of Pseudomonas aeruginosa Biofilms In vitro
H. Bandara (2014)
10.1128/AAC.43.12.2975
Characterization of a Pseudomonas aeruginosa Efflux Pump Contributing to Aminoglycoside Impermeability
S. Westbrock-Wadman (1999)
10.4155/fmc.13.80
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.
Kristin J Labby (2013)
10.1099/jmm.0.000492
Exposure to sub‐inhibitory concentrations of gentamicin, ciprofloxacin and cefotaxime induces multidrug resistance and reactive oxygen species generation in meticillin‐sensitive Staphylococcus aureus
G. Bhattacharya (2017)
10.1016/j.addr.2008.09.001
Polysaccharides-based nanoparticles as drug delivery systems.
Z. Liu (2008)
10.1021/acschembio.6b01139
Polypharmacology Approaches against the Pseudomonas aeruginosa MvfR Regulon and Their Application in Blocking Virulence and Antibiotic Tolerance.
D. Maura (2017)
Polypharmacology approaches against
F Lepine (2017)
10.3390/md15060167
Synergistic Antibacterial Effects of Chitosan-Caffeic Acid Conjugate against Antibiotic-Resistant Acne-Related Bacteria
Jihoon Kim (2017)
10.1128/AAC.50.4.1489-1496.2006
Binding of Neomycin-Class Aminoglycoside Antibiotics to Mutant Ribosomes with Alterations in the A Site of 16S rRNA
S. Hobbie (2006)
10.1186/gb-spotlight-20020227-01
Extracellular DNA
J. Weitzman (2002)
10.1128/AAC.00415-17
Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms
M. Habash (2017)
10.1007/s13404-015-0162-4
Effect of biofabricated gold nanoparticle-based antibiotic conjugates on minimum inhibitory concentration of bacterial isolates of clinical origin
T. Roshmi (2015)
10.1016/j.cis.2013.12.011
Microbial synthesis of gold nanoparticles: current status and future prospects.
U. Shedbalkar (2014)
10.1128/AAC.01547-05
Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa
Clement Mugabe (2006)
10.2807/ESW.10.04.02626-EN
Emergence and dissemination of a new mechanism of resistance to aminoglycosides in Gram-negative bacteria: 16S rRNA methylation.
M. Galimand (2005)
10.1038/s41467-018-04059-1
Evolution of high-level resistance during low-level antibiotic exposure
Erik Wistrand-Yuen (2018)
10.1128/AAC.01606-12
Full and Broad-Spectrum In Vivo Eradication of Catheter-Associated Biofilms Using Gentamicin-EDTA Antibiotic Lock Therapy
Ashwini Chauhan (2012)
10.1016/j.ijpharm.2009.11.033
Liposomes as delivery systems for antibiotics.
Z. Drulis-Kawa (2010)
10.1007/S12668-017-0496-X
Diversity of Bacterial Synthesis of Silver Nanoparticles
Aqib Javaid (2018)
10.1016/J.NHTM.2016.04.002
Development and characterization of chitosan-based antimicrobial films incorporated with streptomycin loaded starch nanoparticles
N. Hari (2016)
10.3390/molecules22081370
Metal-Based Nanoparticles for the Treatment of Infectious Diseases
B. Aderibigbe (2017)
Antibiotic resis
Z Pang (2019)
10.1002/jor.23656
Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated orthopedic infections
Bingyun Li (2018)
10.1039/C7ME00048K
Advancements on the molecular design of nanoantibiotics: current level of development and future challenges
R. Jijie (2017)
10.1371/journal.pone.0134684
Quercetin Influences Quorum Sensing in Food Borne Bacteria: In-Vitro and In-Silico Evidence
V. Gopu (2015)
10.1038/nrd.2017.23
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
S. W. Dickey (2017)
10.3390/jfb10020026
Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
M. Hill (2019)
10.1039/C5NJ00007F
Synthesis and antimicrobial activity of aminoglycoside-conjugated silica nanoparticles against clinical and resistant bacteria
Shrish Agnihotri (2015)
10.3389/fmicb.2012.00408
MexXY multidrug efflux system of Pseudomonas aeruginosa
Y. Morita (2012)
10.4155/tde.14.13
Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.
M. Alipour (2014)
10.1016/J.IJANTIMICAG.2004.07.015
Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
K. Morikawa (2005)
10.4137/PMC.S2381
Aminoglycosides: Molecular Insights on the Recognition of RNA and Aminoglycoside Mimics
Maruthi Chittapragada (2009)
10.3389/fmicb.2019.02091
A State-of-Art Review on Multi-Drug Resistant Pathogens in Foods of Animal Origin: Risk Factors and Mitigation Strategies
F. Pérez-Rodríguez (2019)
10.1128/mmbr.52.1.153-153.1988
Mechanism of bactericidal action of aminoglycosides.
B. Davis (1987)
Labby KJ (2016) Mechanisms of resistance
S Garneau-Tsodikova (2016)
Development and characterization of chitosan
N Hari (2016)
10.3389/fmicb.2017.02651
Mycobacterium Biofilms
J. Esteban (2018)
10.2147/IJN.S141709
Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities
M. Alhariri (2017)
10.1101/cshperspect.a027029
Aminoglycosides: An Overview.
K. Krause (2016)
10.1128/AAC.01650-15
Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa
Mike Wilton (2015)
10.3389/fmicb.2016.00607
Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity
Jason N. Payne (2016)
10.1016/j.ijpharm.2017.06.052
Polymeric nanoparticles: Promising platform for drug delivery.
K. El-Say (2017)
10.3389/fmicb.2019.00513
Genetic Relationship, Virulence Factors, Drug Resistance Profile and Biofilm Formation Ability of Vibrio parahaemolyticus Isolated From Mussel
Md Ashrafudoulla (2019)
Primary mechanisms mediat
Y Morita (2012)
Liposome-based drug delivery systems.
M. Langner (1999)
10.1590/S1517-838246120140218
Sub-MIC of antibiotics induced biofilm formation of Pseudomonas aeruginosa in the presence of chlorhexidine
S. T. Aka (2015)
10.5923/J.NN.20120202.04
Gold Nanoparticles Conjugated Antibiotics: Stability and Functional Evaluation
D. Bhattacharya (2012)
2016a) Gold nanoparticles
H Mu (2016)
Synergistic antibacterial effect
WK Jung (2016)
A (2006a) Preparation and characteriza
C Mugabe (2006)
Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
P. Noone (1984)
10.3389/fmicb.2015.00841
Intra- and inter-species interactions within biofilms of important foodborne bacterial pathogens
E. Giaouris (2015)
Potent antibacterial
MuH 1093glycobcww (2016)
Kostrub CF (2011) In vivo efficacy of the novel
N Reyes (2011)
Antibiotic resistance mechanisms in bacteria
E Peterson (2018)
10.3390/molecules23020284
Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors
S. Zárate (2018)
10.1128/AAC.2.3.136
Mechanisms and Spectrum of Streptomycin Resistance in a Natural Population of Pseudomonas aeruginosa
Jui Teng Tseng (1972)
10.2174/1389450120666181123123333
Functional Diversity of Quorum Sensing Receptors in Pathogenic Bacteria: Interspecies, Intraspecies and Interkingdom Level.
Fazlurrahman Khan (2019)
10.1099/jmm.0.068130-0
Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent.
M. Henry-Stanley (2014)
10.1086/656788
Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
G. Herrmann (2010)
10.1016/j.cell.2012.12.019
Riboswitch Control of Aminoglycoside Antibiotic Resistance
Xu Jia (2013)
10.2147/DDDT.S190577
Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles
Vo Van Giau (2019)
Triclosan is an aminoglycoside adjuvant
MH (2018)
Petri DFS (2018) Microbicidal gentamicinalginate hydrogels
S Kondaveeti (2018)
Aminoglycoside-modifying enzymes.
J. Davies (1979)
Combination susceptibility testing
B Yang (2017)
10.4014/jmb.1511.11046
Synergistic Antibacterial Effect and Antibacterial Action Mode of Chitosan-Ferulic Acid Conjugate against Methicillin-Resistant Staphylococcus aureus.
Sung-Hwan Eom (2016)
10.3762/bjnano.9.98
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
J. Jeevanandam (2018)
Aminoglycosides: a practical review.
L. Gonzalez (1998)
10.1016/j.biotechadv.2018.11.013
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Zheng Pang (2019)
10.1007/s00253-016-7793-0
Streptomycin favors biofilm formation by altering cell surface properties
A. Kumar (2016)
10.1016/0007-6813(65)90067-4
The synergistic effect
J. Mee (1965)
10.1016/j.jconrel.2014.11.022
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
J. Deacon (2015)
10.5301/ijao.5000027
Antibiotic-Induced Biofilm Formation
J. Kaplan (2011)
10.1093/jac/dkp224
Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
Yun Cai (2009)
10.1007/s00253-018-9315-8
Attenuation of Pseudomonas aeruginosa biofilm by hordenine: a combinatorial study with aminoglycoside antibiotics
Jin-wei Zhou (2018)
10.1128/AEM.03119-09
Role of Extracellular DNA in Initial Bacterial Adhesion and Surface Aggregation
Theerthankar Das (2010)
10.1371/journal.pone.0137751
Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii
Bora Shin (2015)
10.1128/IAI.01652-14
Catheter-Associated Urinary Tract Infection by Pseudomonas aeruginosa Is Mediated by Exopolysaccharide-Independent Biofilms
Stephanie J. Cole (2014)
10.1038/nature03912
Aminoglycoside antibiotics induce bacterial biofilm formation
L. Hoffman (2005)
10.1128/AAC.47.5.1577-1583.2003
Aminoglycoside Resistance Resulting from Tight Drug Binding to an Altered Aminoglycoside Acetyltransferase
S. Magnet (2003)
10.1016/J.IJANTIMICAG.2005.10.021
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
Gavin Rukholm (2006)
Reshaping antibiotics through hydrophobic drug
M Ricci (2017)
10.1039/C6MD00079G
Structural modifications of the neomycin class of aminoglycosides
Smritilekha Bera (2016)
Combination therapy strategy
XW (2018)
10.3390/ijms18040784
Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm
Y. Hou (2017)
10.1039/C5RA22803D
Gold nanoparticles make chitosan–streptomycin conjugates effective towards Gram-negative bacterial biofilm
H. Mu (2016)
10.1586/eri.11.121
Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents
A. Allahverdiyev (2011)
10.1016/j.ijpharm.2017.06.008
Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms.
S. Giovagnoli (2017)
10.1128/AAC.00146-18
Triclosan Is an Aminoglycoside Adjuvant for Eradication of Pseudomonas aeruginosa Biofilms
Michael M. Maiden (2018)
10.3389/fmicb.2018.01441
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
P. Baptista (2018)
Enhancement of antimicrobial
MH Anderson (2006)
10.1111/aogs.12945
State‐of‐the‐art review
J. Langhoff-Roos (2016)
10.3390/genes8010039
The Complex Relationship between Virulence and Antibiotic Resistance
M. Schroeder (2017)
10.1016/j.ijantimicag.2009.12.011
Antibiotic resistance of bacterial biofilms.
N. Høiby (2010)
10.1093/jac/dkq459
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City.
D. Landman (2011)
10.1038/s41598-018-37176-4
Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening
Hasan Tükenmez (2019)
10.1016/j.ijantimicag.2017.08.024
Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus.
Martin Vestergaard (2018)
10.1093/infdis/jiu286
pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
D. Lebeaux (2014)
10.1128/AAC.00862-10
In Vivo Efficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models
N. Reyes (2011)
10.3389/fmicb.2018.02928
Antibiotic Resistance Mechanisms in Bacteria: Relationships Between Resistance Determinants of Antibiotic Producers, Environmental Bacteria, and Clinical Pathogens
Elizabeth Peterson (2018)
10.1016/S1367-5931(99)00028-9
Aminoglycoside-RNA interactions.
F. Walter (1999)
10.1128/AAC.45.10.2877-2884.2001
Mechanisms of Streptomycin Resistance: Selection of Mutations in the 16S rRNA Gene Conferring Resistance
B. Springer (2001)
10.1038/s41579-018-0141-x
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
M. Tyers (2019)
10.1080/03071848109441952
A Complex Relationship
John Terraine (1981)
10.3389/fmicb.2017.02125
Combination Susceptibility Testing of Common Antimicrobials in Vitro and the Effects of Sub-MIC of Antimicrobials on Staphylococcus aureus Biofilm Formation
Bing Yang (2017)
10.1128/AEM.02474-05
Influences of Biofilm Structure and Antibiotic Resistance Mechanisms on Indirect Pathogenicity in a Model Polymicrobial Biofilm
H. A. O'Connell (2006)
10.1111/J.1541-4337.2011.00150.X
Bacterial Quorum Sensing and Food Industry
A. J. Bai (2011)
10.1021/acs.molpharmaceut.8b00011
PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
Tania F Bahamondez-Canas (2018)
10.1111/1574-6968.12086
Antibiotics at subinhibitory concentrations improve the quorum sensing behavior of Chromobacterium violaceum.
Z. Liu (2013)
10.1111/lam.12401
Synergy among thymol, eugenol, berberine, cinnamaldehyde and streptomycin against planktonic and biofilm‐associated food‐borne pathogens
Q. Liu (2015)
10.1016/j.peptides.2014.09.021
Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides
S. Dosler (2014)
10.1007/S11373-007-9194-Y
Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
S. Shakil (2008)
10.1073/pnas.0608949103
Antibiotics as intermicrobial signaling agents instead of weapons
J. F. Linares (2006)
10.1111/J.1541-4337.2003.TB00012.X
Biofilm Formation and Control in Food Processing Facilities
R. Chmielewski (2003)
10.1021/acs.jafc.7b05035
Hordenine: A Novel Quorum Sensing Inhibitor and Antibiofilm Agent against Pseudomonas aeruginosa.
Jin-wei Zhou (2018)
10.1016/j.ijantimicag.2014.02.009
Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.
N. Abed (2014)
10.5772/INTECHOPEN.69056
Synthetic Polymer-Based Nanoparticles: Intelligent Drug Delivery Systems
V. Andonova (2017)
Effects of antibiotics on Pseudomonas
P Di Martino (2004)
10.1128/MMBR.51.4.439-457.1987
Bacterial uptake of aminoglycoside antibiotics.
H. Taber (1987)
10.3389/fmicb.2015.00034
Mechanisms of antibiotic resistance
Jun Lin (2015)
10.1093/femsle/fnz026
Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs) Escherichia coli.
Y. Hou (2019)
10.1371/journal.ppat.1000213
Extracellular DNA Chelates Cations and Induces Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
H. Mulcahy (2008)
10.2174/1389201019666180828090052
Recent Progress and Future Perspectives of Antibiofilm Drugs Immobilized on Nanomaterials.
Fazlurrahman Khan (2018)
10.1128/AAC.00311-13
Antimicrobial Peptide GL13K Is Effective in Reducing Biofilms of Pseudomonas aeruginosa
H. Hirt (2013)
10.1016/j.tim.2016.06.009
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
G. Wright (2016)
10.1099/jmm.0.000430
Improved effect of amikacin‐loaded poly(D,L‐lactide‐co‐glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa
Parastoo Sabaeifard (2017)
10.1038/srep03364
Chitosan Coupling Makes Microbial Biofilms Susceptible to Antibiotics
Amin Zhang (2013)
10.1155/2013/871097
Enhancement of Antibacterial Activity of Capped Silver Nanoparticles in Combination with Antibiotics, on Model Gram-Negative and Gram-Positive Bacteria
Aruna Jyothi Kora (2013)
10.1016/j.heliyon.2018.e00562
Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics
Priya Kapoor (2018)
10.3389/fcimb.2019.00074
Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition
Osmel Fleitas Martínez (2019)
Emergence and dissemina
T Lambert (2005)
Antimicrobial peptide GL13K is effective
SU Gorr (2013)
10.1592/phco.31.6.598
Monotherapy or Combination Therapy? The Pseudomonas aeruginosa Conundrum
K. Traugott (2011)
10.1021/acs.jmedchem.8b01781
Antibiotic Adjuvants: Make Antibiotics Great Again!
Hana Douafer (2019)
10.1038/s41522-019-0088-3
Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Pseudomonas aeruginosa tobramycin-enhanced biofilm formation
A. Tahrioui (2019)
tric oxide and antibiotic using polymeric nanoparticles †
Thuy-Khanh Nguyen (2016)
10.1179/joc.2004.16.3.244
Effects of Antibiotics on Pseudomonas aeruginosa NK125502 and Pseudomonas fluorescens MF0 Biofilm Formation on Immobilized Fibronectin
H. Gagnière (2004)
10.1007/S10156-004-0336-0
Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model
Yuka Yoshikawa (2004)
10.3892/etm.2017.5110
Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing
Warren Chanda (2017)
10.1016/j.fm.2014.04.015
Biofilm-associated persistence of food-borne pathogens.
A. Bridier (2015)
10.1099/mic.0.000453
Effect of subinhibitory concentrations of tigecycline and ciprofloxacin on the expression of biofilm-associated genes and biofilm structure of Staphylococcus epidermidis
E. Szczuka (2017)
10.1111/j.1365-2958.2009.06739.x
Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress
A. Böhm (2009)
10.1093/glycob/cww079
Chitosan conjugation enables intracellular bacteria susceptible to aminoglycoside antibiotic.
H. Mu (2016)
Formulation of ceftriaxone conjugated gold nanoparticles and their medical applications against extended-spectrum β-Lactamase producing bacteria and breast cancer.
Sanaa M. F. Gad El-Rab (2018)
Aminoglycosides: a practical
JP Spencer (1998)
Anti-virulence strategies to combat
DA Rasko (2010)
10.1080/14786419.2017.1366485
Antimicrobial and anti-biofilm activity of tannic acid against Staphylococcus aureus
G. Dong (2018)
Chitosan improves
F Guo (2014)
Infect Ther 9(11):1035–1052
GG Anderson (2013)
2018b) Hordenine: a novel quorum sensing inhibitor and antibiofilm agent against Pseudomonas aeruginosa
JW Zhou (2018)
10.3389/fcimb.2018.00444
Interference With Quorum-Sensing Signal Biosynthesis as a Promising Therapeutic Strategy Against Multidrug-Resistant Pathogens
Osmel Fleitas Martínez (2019)
10.1128/AAC.01495-10
Oxidative Stress Induction of the MexXY Multidrug Efflux Genes and Promotion of Aminoglycoside Resistance Development in Pseudomonas aeruginosa
S. Fraud (2010)
10.1128/AAC.44.12.3249-3256.2000
Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance
L. Kotra (2000)
10.1016/j.jconrel.2017.01.003
A smart aminoglycoside hydrogel with tunable gel degradation, on‐demand drug release, and high antibacterial activity
Jingjing Hu (2017)
10.1128/JCM.37.6.1771-1776.1999
The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms
H. Ceri (1999)
10.1038/NBT1184-979
Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes
C. Kirby (1984)
10.3389/fmicb.2019.00539
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
M. Mulani (2019)
10.1038/s41598-018-19504-w
Combination Therapy Strategy of Quorum Quenching Enzyme and Quorum Sensing Inhibitor in Suppressing Multiple Quorum Sensing Pathways of P. aeruginosa
July Fong (2018)
10.4014/jmb.1711.11037
Formulation of Ceftriaxone Conjugated Gold Nanoparticles and Their Medical Applications against Extended-Spectrum β-Lactamase Producing Bacteria and Breast Cancer.
Sanaa M. F. Gad El-Rab (2018)
10.5772/58423
Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
M. Salouti (2014)
Gold nanoparticles: various methods
R Dakshinamurthy (2014)
MexXY multidrug efflux
Y ijantimicag.2004.07.015 Morita (2012)
10.1039/C5MD00344J
Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.
Sylvie Garneau-Tsodikova (2016)
10.1016/j.ijbiomac.2017.01.121
Gentamicin modified chitosan film with improved antibacterial property and cell biocompatibility.
Y. Liu (2017)
10.3205/dgkh000302
In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa
H. Ghorbani (2017)
10.1016/j.carbpol.2018.01.044
Microbicidal gentamicin-alginate hydrogels.
Stalin Kondaveeti (2018)
10.1007/s12223-008-0008-z
Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa
L. Černohorská (2008)
10.2147/IJN.S53079
Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic
S. Hussein-Al-Ali (2014)
10.3390/ijms18051077
Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype
E. G. Di Domenico (2017)
10.3389/fmicb.2013.00103
The intrinsic resistome of bacterial pathogens
J. Olivares (2013)
10.1128/AAC.00509-06
Enhancement of Antimicrobial Activity against Pseudomonas aeruginosa by Coadministration of G10KHc and Tobramycin
R. Eckert (2006)
10.1039/C4RA10023A
Continuous release of gentamicin from gold nanocarriers
S. Perni (2014)
10.1007/s00253-019-10190-w
Streptomycin mediated biofilm inhibition and suppression of virulence properties in Pseudomonas aeruginosa PAO1
Fazlurrahman Khan (2019)
10.1016/j.chembiol.2019.07.009
Chemical Induction of Aminoglycoside Uptake Overcomes Antibiotic Tolerance and Resistance in Staphylococcus aureus.
L. Radlinski (2019)
10.3390/md17010043
Synthesis and Evaluation of a Chitosan Oligosaccharide-Streptomycin Conjugate against Pseudomonas aeruginosa Biofilms
R. Li (2019)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar